| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dd98ad4ee076841fec541542f952f58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
| filingDate |
2016-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c15738c861d8056a10e0ef30f819b63b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb5eb781fc256a123ae88c35cd846a33 |
| publicationDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016303081-A1 |
| titleOfInvention |
Inhibitors of beta1-integrin and methods of use |
| abstract |
The present disclosure provides compositions and methods for inhibiting β1-integrin expression and functionality, and for addressing any condition characterized by increased β1-integrin levels, through inhibition of NR4A1 (TR3) in the cell. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115484822-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020530477-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115403501-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114984006-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111263635-A |
| priorityDate |
2015-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |